PDC*line Pharma
Amel is a scientist with Immunology and cellular biology background, experienced in cell therapy development from R&D to clinical phase, Business Development and Company Development strategy. Continuous learning and training on the Managerial and Entrepreneurial aspect of the Biotech Industry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
PDC*line Pharma
PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells.